These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11552772)

  • 1. An open naltrexone treatment study in pathological gambling disorder.
    Kim SW; Grant JE
    Int Clin Psychopharmacol; 2001 Sep; 16(5):285-9. PubMed ID: 11552772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling.
    Kim SW; Grant JE; Adson DE; Shin YC
    Biol Psychiatry; 2001 Jun; 49(11):914-21. PubMed ID: 11377409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label study of naltrexone in the treatment of kleptomania.
    Grant JE; Kim SW
    J Clin Psychiatry; 2002 Apr; 63(4):349-56. PubMed ID: 12000210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.
    Grant JE; Kim SW; Hartman BK
    J Clin Psychiatry; 2008 May; 69(5):783-9. PubMed ID: 18384246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nefazodone treatment of pathological gambling: a prospective open-label controlled trial.
    Pallanti S; Baldini Rossi N; Sood E; Hollander E
    J Clin Psychiatry; 2002 Nov; 63(11):1034-9. PubMed ID: 12444818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
    Grant JE; Potenza MN; Hollander E; Cunningham-Williams R; Nurminen T; Smits G; Kallio A
    Am J Psychiatry; 2006 Feb; 163(2):303-12. PubMed ID: 16449486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic and clinical features of 131 adult pathological gamblers.
    Grant JE; Kim SW
    J Clin Psychiatry; 2001 Dec; 62(12):957-62. PubMed ID: 11780876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of pharmacotherapy for pathological gambling: a chart review.
    Grant JE; Kim SW
    Ann Clin Psychiatry; 2002 Sep; 14(3):155-61. PubMed ID: 12585565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study.
    Dannon PN; Lowengrub K; Musin E; Gonopolski Y; Kotler M
    J Clin Psychopharmacol; 2005 Dec; 25(6):593-6. PubMed ID: 16282845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study.
    Dannon PN; Lowengrub K; Musin E; Gonopolsky Y; Kotler M
    J Clin Psychopharmacol; 2007 Dec; 27(6):620-4. PubMed ID: 18004130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study.
    Kim SW; Grant JE; Potenza MN; Blanco C; Hollander E
    Psychiatry Res; 2009 Mar; 166(1):76-84. PubMed ID: 19200607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy outcome in older pathological gamblers: a preliminary investigation.
    Grant JE; Grosz R
    J Geriatr Psychiatry Neurol; 2004 Mar; 17(1):9-12. PubMed ID: 15018691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term single-blind fluvoxamine treatment of pathological gambling.
    Hollander E; DeCaria CM; Mari E; Wong CM; Mosovich S; Grossman R; Begaz T
    Am J Psychiatry; 1998 Dec; 155(12):1781-3. PubMed ID: 9842795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of high-dose naltrexone treatment: hepatic transaminase profiles among outpatients.
    Kim SW; Grant JE; Yoon G; Williams KA; Remmel RP
    Clin Neuropharmacol; 2006; 29(2):77-9. PubMed ID: 16614539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label study of citalopram in the treatment of pathological gambling.
    Zimmerman M; Breen RB; Posternak MA
    J Clin Psychiatry; 2002 Jan; 63(1):44-8. PubMed ID: 11838625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling.
    Kim SW; Grant JE; Adson DE; Shin YC; Zaninelli R
    J Clin Psychiatry; 2002 Jun; 63(6):501-7. PubMed ID: 12088161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Petry NM; Stinson FS; Grant BF
    J Clin Psychiatry; 2005 May; 66(5):564-74. PubMed ID: 15889941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial.
    McElroy SL; Nelson EB; Welge JA; Kaehler L; Keck PE
    J Clin Psychiatry; 2008 Mar; 69(3):433-40. PubMed ID: 18251624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sertraline treatment of pathological gambling: a pilot study.
    Saiz-Ruiz J; Blanco C; Ibáñez A; Masramon X; Gómez MM; Madrigal M; Díez T
    J Clin Psychiatry; 2005 Jan; 66(1):28-33. PubMed ID: 15669885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?
    Hollander E; Pallanti S; Allen A; Sood E; Baldini Rossi N
    Am J Psychiatry; 2005 Jan; 162(1):137-45. PubMed ID: 15625212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.